Pages that link to "Q57392965"
Jump to navigation
Jump to search
The following pages link to Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection (Q57392965):
Displaying 50 items.
- Pertussis: challenges today and for the future (Q21131377) (← links)
- Needle size for vaccination procedures in children and adolescents (Q24187107) (← links)
- Acellular vaccines for preventing whooping cough in children (Q24193554) (← links)
- The pertussis enigma: reconciling epidemiology, immunology and evolution (Q26772095) (← links)
- Roads to the development of improved pertussis vaccines paved by immunology (Q26782939) (← links)
- Vaccine Adjuvants: from 1920 to 2015 and Beyond (Q26783879) (← links)
- The re-emergency and persistence of vaccine preventable diseases (Q26796600) (← links)
- Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience (Q26822908) (← links)
- Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function (Q27318916) (← links)
- Pertussis: Microbiology, Disease, Treatment, and Prevention (Q30251684) (← links)
- Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin. (Q30274818) (← links)
- The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies (Q30301113) (← links)
- Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis (Q30656264) (← links)
- Vaccine preventable diseases: time to re-examine global surveillance data? (Q30776743) (← links)
- New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. (Q30994981) (← links)
- Different effects of whole-cell and acellular vaccines on Bordetella transmission (Q33684401) (← links)
- How advances in immunology provide insight into improving vaccine efficacy. (Q33896995) (← links)
- Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine (Q34260834) (← links)
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model (Q34387963) (← links)
- A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. (Q35533082) (← links)
- Identification of pertussis-specific effector memory T cells in preschool children (Q35548052) (← links)
- Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates (Q35566869) (← links)
- Asymptomatic transmission and the resurgence of Bordetella pertussis (Q35672136) (← links)
- Combination vaccines against diarrheal diseases (Q35896237) (← links)
- Examining the role of different age groups, and of vaccination during the 2012 Minnesota pertussis outbreak (Q35960441) (← links)
- Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013. (Q36039358) (← links)
- Laboratory Diagnosis of Pertussis. (Q36073693) (← links)
- Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation (Q36109040) (← links)
- Strategies and new developments to control pertussis, an actual health problem (Q36226470) (← links)
- What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine (Q36226482) (← links)
- Bordetella pertussis transmission (Q36226634) (← links)
- Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1-18 years. (Q36436918) (← links)
- Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis (Q36457650) (← links)
- Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy (Q36688886) (← links)
- Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis (Q36783198) (← links)
- Licensed pertussis vaccines in the United States. History and current state (Q37154787) (← links)
- Effectiveness of pertussis vaccination and duration of immunity. (Q37382056) (← links)
- Unraveling the challenges of pertussis (Q37495317) (← links)
- Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis (Q37613218) (← links)
- How to fight pertussis? (Q37668385) (← links)
- Global population structure and evolution of Bordetella pertussis and their relationship with vaccination (Q37714873) (← links)
- Perplexities of pertussis: recent global epidemiological trends and their potential causes (Q38074502) (← links)
- Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin (Q38081288) (← links)
- Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries (Q38115933) (← links)
- Epidemiology of whooping cough & typing of Bordetella pertussis (Q38160533) (← links)
- Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations (Q38168915) (← links)
- Live attenuated vaccines against pertussis (Q38236200) (← links)
- Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology (Q38237077) (← links)
- The baboon model of pertussis: effective use and lessons for pertussis vaccines (Q38245642) (← links)
- Investigating pertussis toxin and its impact on vaccination (Q38358628) (← links)